Text Size
2 studies found for:    18784101 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Cisplatin and 5-FU +/- Panitumumab for Patients With Nonresectable,Advanced or Metastatic Esophageal Squamous Cell Cancer
Condition: Esophageal Squamous Cell Cancer
Interventions: Drug: Cisplatin, 5-FU;   Drug: Panitumumab
2 Completed
Has Results 		Cetuximab (Erbitux) in Combination With Cisplatin or Carboplatin and 5-Fluorouracil in the First Line Treatment of Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (EXTREME)
Condition: Head and Neck Cancer
Interventions: Drug: Cetuximab + Platinum (Cisplatin or Carboplatin) + 5Fluorouracil (5-FU);   Drug: Platinum (Cisplatin or Carboplatin) + 5-FU
To Top

† Indicates status has not been verified in more than two years